Medicare Enrolled
Dr. Sachin Mehta, M.D.
Interventional Cardiology · Austin, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mehta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mehta?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mehta
Dr. Sachin Mehta is an interventional cardiology specialist in Austin, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Mehta performed 3,643 Medicare services across 2,346 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mehta received a total of $7,790 from 30 pharmaceutical and/or device companies across 291 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mehta is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 27% volume in TX
$7,790 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,643
Medicare services
Top 27% in TX for interventional cardiology
2,346
Unique beneficiaries
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~214 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
806 | $85 | $321 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
231 | $18 | $82 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
212 | $92 | $310 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
186 | $4 | $15 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
182 | $62 | $216 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
176 | $45 | $159 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
135 | $139 | $630 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
131 | $28 | $260 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
122 | $10 | $38 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
108 | $101 | $406 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
96 | $129 | $584 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
94 | $123 | $434 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
82 | $90 | $363 |
| Cardiac catheterization | 78 | $180 | $979 |
| Perflutren lipid microspheres injection Injection of perflutren lipid microspheres, measured per milliliter. |
76 | $35 | $149 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
66 | $125 | $494 |
| Radiofrequency vein destruction, first vein A procedure to treat the first incompetent vein in the arm or leg using radiofrequency energy and imaging guidance. |
65 | $896 | $5,294 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
64 | $96 | $330 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
63 | $51 | $220 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
62 | $364 | $1,523 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
62 | $51 | $443 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
51 | $131 | $603 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
46 | $10 | $44 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
41 | $162 | $663 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
40 | $78 | $405 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
38 | $180 | $780 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
36 | $65 | $219 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
34 | $72 | $314 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
34 | $15 | $67 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
29 | $136 | $603 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
27 | $427 | $1,779 |
| Intravascular ultrasound of heart vessel, initial An ultrasound procedure used to evaluate a blood vessel within the heart during a diagnostic or treatment procedure. |
24 | $55 | $314 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
23 | $17 | $79 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
20 | $83 | $360 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
20 | $14 | $60 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
20 | $2 | $10 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 16 | $257 | $1,242 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
13 | $65 | $247 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
12 | $84 | $329 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
11 | $8 | $44 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
11 | $17 | $76 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.1% high complexity
24.8% medium
68.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,790
Total received (2018-2024)
Avg $1,113/year across 7 years
Bottom 46% in TX for interventional cardiology
30
Companies
291
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,790 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$235
2023
$593
2022
$949
2021
$251
2020
$271
2019
$1,841
2018
$3,650
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Terumo Medical Corporation
$2,831
Medtronic Vascular, Inc.
$1,209
Janssen Pharmaceuticals, Inc
$682
BIOTRONIK INC.
$573
Inari Medical, Inc.
$384
Amgen Inc.
$353
ABIOMED
$280
PFIZER INC.
$238
HeartFlow, Inc.
$226
Abbott Laboratories
$200
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$112
Cardiovascular Systems Inc.
$100
Boston Scientific Corporation
$100
Philips Electronics North America Corporation
$79
Novartis Pharmaceuticals Corporation
$60
Otsuka America Pharmaceutical, Inc.
$46
Lundbeck LLC
$40
Amarin Pharma Inc.
$35
Acist Medical Systems, Inc.
$31
Actelion Pharmaceuticals US, Inc.
$31
Edwards Lifesciences Corporation
$30
Gilead Sciences, Inc.
$29
iRhythm Technologies, Inc.
$22
Tactile Systems Technology Inc
$16
SANOFI-AVENTIS U.S. LLC
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Esperion Therapeutics, Inc.
$14
W. L. Gore & Associates, Inc.
$14
AstraZeneca Pharmaceuticals LP
$13
Medtronic, Inc.
$11
Top 3 companies account for 60.6% of total payments
Associated products mentioned in payments ›
(4067) Tack Endovascular Systems BTK · (9520) IGT Devices Und · AngioSeal · BRILINTA · CHANTIX · CVI Consumables · ClosureFast · ClosureRFS · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · Diamondback Coronary · Diamondback Peripheral · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · FLEXITOUCH · FLOWTRIEVER CATHETER · GLIDEWIRE · GORE VIABAHN VBX Balloon Expandable Endo · General - Stents · GlideWire · Glidesheath · HD-IVUS · HEARTRAIL · HawkOne · Impella · LifeVest · METACROSS OTW · MetaCross · Misago · NEXLETOL · NORTHERA · Navicross · OPSUMIT · Omnilink Elite vascular stent system · Orsiro Mission · PRADAXA · PRALUENT · Peripheral Orbital Atherectomy System · PressureWire FFR · R2P MISAGO · ReCross · Repatha · S · SAMSCA · Supera peripheral stent system · Vascepa · VenaSeal · XARELTO · Xience Sierra Coronary Stent · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $214 per 100 Medicare services performed
Geographic Context
Interventional cardiologists within 10 mi
23
Per 100K population
1.8
County median income
$97,169
Nearest hospital
AUSTIN OAKS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mehta is a clinical cardiology specialist, with above-average Medicare volume (top 27% in TX), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mehta experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mehta performed 806 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mehta receive payments from pharmaceutical companies?
Yes. Dr. Mehta received a total of $7,790 from 30 companies across 291 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mehta's costs compare to other interventional cardiologists in Austin?
Dr. Mehta's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mehta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Austin
Browse interventional cardiologists in Austin ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in TX
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in TX
Which TX interventional cardiologists receive the most from drug and device companies.
By company
Terumo Medical Corporation Payments to Doctors
See all physicians who received payments from Terumo Medical Corporation.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology